PMV Pharmaceuticals (NASDAQ:PMVP) & Rock Creek Pharmaceuticals (OTCMKTS:RCPIQ) Head-To-Head Review

Rock Creek Pharmaceuticals (OTCMKTS:RCPIQ) and PMV Pharmaceuticals (NASDAQ:PMVP) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.

Insider and Institutional Ownership

90.2% of PMV Pharmaceuticals shares are held by institutional investors. 0.9% of Rock Creek Pharmaceuticals shares are held by company insiders. Comparatively, 7.6% of PMV Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares Rock Creek Pharmaceuticals and PMV Pharmaceuticals”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rock Creek Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
PMV Pharmaceuticals	N/A	N/A	-$77.74 million	($1.49)	-0.74

Analyst Ratings

This is a summary of current recommendations and price targets for Rock Creek Pharmaceuticals and PMV Pharmaceuticals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rock Creek Pharmaceuticals	0	0	0	0	0.00
PMV Pharmaceuticals	1	0	1	1	2.67

PMV Pharmaceuticals has a consensus target price of $5.00, suggesting a potential upside of 352.49%. Given PMV Pharmaceuticals’ stronger consensus rating and higher possible upside, analysts plainly believe PMV Pharmaceuticals is more favorable than Rock Creek Pharmaceuticals.

Profitability

This table compares Rock Creek Pharmaceuticals and PMV Pharmaceuticals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Rock Creek Pharmaceuticals	N/A	N/A	N/A
PMV Pharmaceuticals	N/A	-68.98%	-62.70%

Summary

PMV Pharmaceuticals beats Rock Creek Pharmaceuticals on 6 of the 8 factors compared between the two stocks.

About Rock Creek Pharmaceuticals

Rock Creek Pharmaceuticals, Inc. is an early stage life science company, which engages in the discovery, development, and commercialization of new drugs, formulations, and compounds that provide therapies for chronic and acute inflammatory diseases. It focuses on small molecule therapeutics that exhibit anti-inflammatory pharmacological characteristics. The company was founded by Jonnie R. Williams, Sr. on June 24, 1985 and is headquartered in Sarasota, FL.

About PMV Pharmaceuticals

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.